Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgicel vs Endometrial Ablation for HMB
NCT03176992Phase 2Unknown
- Sponsor
- Cairo University
- Start
- Jun 2015
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Heavy menstrual bleeding (3 arms), sponsored by Cairo University. Primary endpoint: Amenorrhea rates at 18 months. Status: unknown.
02
Conditions
Heavy menstrual bleeding
Beyond the preview
Go deeper on NCT03176992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03176992.